NASDAQ:ZNTL | Profit Breakdown | Zentalis Pharmaceuticals, Inc.

Complete filed revenue-to-profit bridge showing gross profit, operating income, pre-tax income and net income.

Available history
2019-03-31 to 2026-06-30
Data captured

Historical Profit Breakdown

DateRevenueGross profitOperating incomePre-tax incomeNet income
2026-06-30-$44.39M-$42.15M-$42.29M
2026-03-31-$37.86M-$35.23M-$35.35M
2025-12-31$0.00-$37.39M-$34.77M-$35.22M
2025-09-30$0.00-$33.73M-$26.69M-$26.69M
2025-06-30$0.00-$36.06M-$26.87M-$26.87M
2025-03-31$0.00-$45.62M-$48.28M-$48.28M
2024-12-31$26.87M-$49.85M-$47.68M-$47.47M
2024-09-30$0.00-$51.43M-$40.19M-$40.16M
2024-06-30$0.00-$65.15M-$88.01M-$88.28M
2024-03-31$40.56M-$24.77M$10.18M$10.07M
2023-12-31$0.00-$67.92M-$77.09M-$60.92M
2023-09-30$0.00-$62.72M-$55.51M-$55.53M
2023-06-30$0.00-$103.92M-$99.47M-$112.53M
2023-03-31$0.00-$64.95M-$60.84M-$63.22M
2022-12-31-$51.75M-$64.8M-$54.97M
2022-09-30-$54.19M-$52.29M-$54.4M
2022-06-30-$63.46M-$63.04M-$68.36M
2022-03-31-$57.88M-$57.45M-$59.08M
2021-12-31-$48.19M-$49.94M-$50.06M
2021-09-30-$62.87M-$11.19M-$4.19M
2021-06-30-$55.13M-$55.02M-$54.57M
2021-03-31-$50.35M-$50.25M-$49.9M
2020-12-31-$40.25M-$39.93M-$40.3M
2020-09-30-$34.77M-$34.65M-$34.56M
2020-06-30-$27.38M-$27.29M-$26.86M
2020-03-31-$16.4M-$16.24M-$16.13M
2019-12-31-$14.91M-$14.55M-$14.51M
2019-09-30-$12.58M-$12.57M-$12.34M
2019-06-30-$10.64M-$10.59M-$10.47M
2019-03-31-$8.72M-$8.66M-$8.34M

Annual Profit Breakdown

DateRevenueGross profitOperating incomePre-tax incomeNet income
2025-12-31$0.00-$152.81M-$136.62M-$137.06M
2024-12-31$67.43M-$191.19M-$165.69M-$165.84M
2023-12-31$0.00-$299.51M-$292.91M-$292.19M
2022-12-31$0.00-$227.29M-$237.58M-$236.81M
2021-12-31-$216.54M-$166.39M-$158.73M
2020-12-31-$118.79M-$118.1M-$117.84M
2019-12-31-$46.85M-$46.36M-$45.66M

Research interface only. Not investment advice. Prices are a checked-in snapshot, not live quotes.